46 research outputs found

    The changing carbon cycle of the coastal ocean

    Get PDF
    The carbon cycle of the coastal ocean is a dynamic component of the global carbon budget. But the diverse sources and sinks of carbon and their complex interactions in these waters remain poorly understood. Here we discuss the sources, exchanges and fates of carbon in the coastal ocean and how anthropogenic activities have altered the carbon cycle. Recent evidence suggests that the coastal ocean may have become a net sink for atmospheric carbon dioxide during post-industrial times. Continued human pressures in coastal zones will probably have an important impact on the future evolution of the coastal ocean's carbon budget

    ICAR: endoscopic skull‐base surgery

    Get PDF
    n/

    Tension type headache in adolescence and childhood: where are we now?

    No full text
    Tension type headache (TTH) is a primary headache disorder considered common in children and adolescents. It remains debatable whether TTH and migraine are separate biological entities. This review summarizes the most recent literature of TTH with regards to children and adolescents. Further studies of TTH are needed to develop a biologically based classification system that may be facilitated through understanding changes in the developing brain during childhood and adolescence

    Anxiety, depression and behavioral problems among adolescents with recurrent headache: the Young-HUNT study

    Get PDF
    Background It is well documented that both anxiety and depression are associated with headache, but there is limited knowledge regarding the relation between recurrent primary headaches and symptoms of anxiety and depression as well as behavioral problems among adolescents. Assessment of co-morbid disorders is important in order to improve the management of adolescents with recurrent headaches. Thus the main purpose of the present study was to assess the relationship of recurrent headache with anxiety and depressive symptoms and behavioral problems in a large population based cross-sectional survey among adolescents in Norway. Methods A cross-sectional, population-based study was conducted in Norway from 1995 to 1997 (Young-HUNT1). In Young-HUNT1, 4872 adolescents aged 12 to 17 years were interviewed about their headache complaints and completed a comprehensive questionnaire that included assessment of symptoms of anxiety and depression and behavioral problems, i.e. conduct and attention difficulties. Results In adjusted multivariate analyses among adolescents aged 12–14 years, recurrent headache was associated with symptoms of anxiety and depression (OR: 2.05, 95% CI: 1.61-2.61, p < 0.001), but not with behavioral problems. A significant association with anxiety and depressive symptoms was evident for all headache categories; i.e. migraine, tension-type headache and non-classifiable headache. Among adolescents aged 15–17 years there was a significant association between recurrent headache and symptoms of anxiety and depression (OR: 1.64, 95% CI: 1.39-1.93, p < 0,001) and attention difficulties (OR: 1.25, 95% CI: 1.09-1.44, p =0.001). For migraine there was a significant association with both anxiety and depressive symptoms and attention difficulties, while tension-type headache was significantly associated only with symptoms of anxiety and depression. Non-classifiable headache was associated with attention difficulties and conduct difficulties, but not with anxiety and depressive symptoms. Headache frequency was significantly associated with increasing symptoms scores for anxiety and depressive symptoms as well as attention difficulties, evident for both age groups. Conclusions The results from the present study indicate that both anxiety and depressive symptoms and behavioral problems are associated with recurrent headache, and should accordingly be considered a part of the clinical assessment of children and adolescents with headache. Identification of these associated factors and addressing them in interventions may improve headache management

    Chronic Tension-Type Headache

    No full text
    A 42-year-old woman was admitted to the emergency room (ER) for the worsening of a continuous headache. She reported of having very frequent headaches for the last couple of years. Last year she had had headaches every day. Headache severity was mild to moderate, bilateral, starting from back of her head, and spreading to the vertex and forehead. She said she took NSAIDs when the pain is moderate. The pain responds moderately to the NSAIDs. Her blood pressure (BP) was found to be 150/90 mmHg; otherwise, the physical examination was normal. She received a diagnosis of headache secondary to hypertension and was treated accordingly. Her BP returned to normal in an hour and then she was referred to the cardiology hypertension outpatient clinic. There, she was diagnosed with essential hypertension and was given an ACE inhibitor. Five months after the first evaluation, despite that her BP remained normal, her headaches did not improve and she went back to her cardiologist who then referred her to the neurology headache outpatient clinic

    Multimodal Physiotherapy Based on a Biobehavioral Approach as a Treatment for Chronic Tension-Type Headache: A Case Report

    No full text
    INTRODUCTION: Tension-type headache (TTH) is the most common primary headache affecting the general population, which is characterized by bilateral headache and mild to moderate pain. This disorder causes high levels of disability and recent scientific evidence suggests that manual therapy (MT) and therapeutic exercise are effective in reducing medication intake and decreasing the frequency and intensity of headaches in patients with TTH. CASE PRESENTATION: A 34-year-old woman was known to have chronic TTH. Initially, the patient presented moderate headaches 5 days per week, mechanical neck pain and no positive response to analgesics. A battery of self-reports was given to the patient to assess disability (using the Spanish versions of the Headache Impact Test-6 and the neck disability index), pain (visual analogue scale) and psychosocial issues (Spanish version of the pain catastrophizing scale) involved in the headaches. All measurements were taken four times during 161 days. Eleven sessions of treatment including MT, motor control therapeutic exercise (MCTE) and therapeutic patient education (TPE) were applied. CONCLUSIONS: This biobehavioral-based multimodal physical rehabilitation treatment combining MT, TPE and MCTE produced a substantial reduction in pain intensity, pain catastrophizing, disability and the impact of headaches on patient’s life

    Structural disorder of monomeric α-synuclein persists in mammalian cells

    No full text
    Intracellular aggregation of the human amyloid protein α-synuclein is causally linked to Parkinson's disease. While the isolated protein is intrinsically disordered, its native structure in mammalian cells is not known. Here we use nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectroscopy to derive atomic-resolution insights into the structure and dynamics of α-synuclein in different mammalian cell types. We show that the disordered nature of monomeric α-synuclein is stably preserved in non-neuronal and neuronal cells. Under physiological cell conditions, α-synuclein is amino-terminally acetylated and adopts conformations that are more compact than when in buffer, with residues of the aggregation-prone non-amyloid-β component (NAC) region shielded from exposure to the cytoplasm, which presumably counteracts spontaneous aggregation. These results establish that different types of crowded intracellular environments do not inherently promote α-synuclein oligomerization and, more generally, that intrinsic structural disorder is sustainable in mammalian cells.Fil: Theillet, Francois Xavier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario. Universidad Nacional de Rosario. Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario; Argentina. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Binolfi, Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario. Universidad Nacional de Rosario. Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario; Argentina. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Bekei, Beata. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Martorana, Andrea. Weizmann Institute of Science. Department of Chemical Physics; IsraelFil: Rose, Honor May. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Stuiver, Marchel. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Verzini, Silvia. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Lorenz, Dorothea. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Van Rossum, Marleen. Forschungsinstitut für Molekulare Pharmakologie; AlemaniaFil: Goldfarb, Daniella. Weizmann Institute of Science. Department of Chemical Physics; IsraelFil: Selenko, Philipp. Forschungsinstitut für Molekulare Pharmakologie; Alemani
    corecore